Literature DB >> 11505338

The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, CARKL, and causes cystinosis if mutated in a critical region.

C Phornphutkul1, Y Anikster, M Huizing, P Braun, C Brodie, J Y Chou, W A Gahl.   

Abstract

Although >55 CTNS mutations occur in patients with the lysosomal storage disorder cystinosis, no regulatory mutations have been reported, because the promoter has not been defined. Using CAT reporter constructs of sequences 5' to the CTNS coding sequence, we identified the CTNS promoter as the region encompassing nucleotides -316 to +1 with respect to the transcription start site. This region contains an Sp-1 regulatory element (GGCGGCG) at positions -299 to -293, which binds authentic Sp-1, as shown by electrophoretic-mobility-shift assays. Three patients exhibited mutations in the CTNS promoter. One patient with nephropathic cystinosis carried a -295 G-->C substitution disrupting the Sp-1 motif, whereas two patients with ocular cystinosis displayed a -303 G-->T substitution in one case and a -303 T insertion in the other case. Each mutation drastically reduced CAT activity when inserted into a reporter construct. Moreover, each failed either to cause a mobility shift when exposed to nuclear extract or to compete with the normal oligonucleotide's mobility shift. The CTNS promoter region shares 41 nucleotides with the promoter region of an adjacent gene of unknown function, CARKL, whose start site is 501 bp from the CTNS start site. However, the patients' CTNS promoter mutations have no effect on CARKL promoter activity. These findings suggest that the CTNS promoter region should be examined in patients with cystinosis who have fewer than two coding-sequence mutations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11505338      PMCID: PMC1226058          DOI: 10.1086/323484

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

1.  Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations.

Authors:  Y Anikster; C Lucero; J Guo; M Huizing; V Shotelersuk; I Bernardini; G McDowell; F Iwata; M I Kaiser-Kupfer; R Jaffe; J Thoene; J A Schneider; W A Gahl
Journal:  Pediatr Res       Date:  2000-01       Impact factor: 3.756

2.  Defective sialic acid egress from isolated fibroblast lysosomes of patients with Salla disease.

Authors:  M Renlund; F Tietze; W A Gahl
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

3.  A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases.

Authors:  F W Verheijen; E Verbeek; N Aula; C E Beerens; A C Havelaar; M Joosse; L Peltonen; P Aula; H Galjaard; P J van der Spek; G M Mancini
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

4.  A bidirectional promoter connects the poly(ADP-ribose) polymerase 2 (PARP-2) gene to the gene for RNase P RNA. structure and expression of the mouse PARP-2 gene.

Authors:  J C Ame; V Schreiber; V Fraulob; P Dolle; G de Murcia; C P Niedergang
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

5.  Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin.

Authors:  M Attard; G Jean; L Forestier; S Cherqui; W van't Hoff; M Broyer; C Antignac; M Town
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

6.  The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion.

Authors:  J W Touchman; Y Anikster; N L Dietrich; V V Maduro; G McDowell; V Shotelersuk; G G Bouffard; S M Beckstrom-Sternberg; W A Gahl; E D Green
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

Review 7.  Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.

Authors:  W A Gahl; E M Kuehl; F Iwata; A Lindblad; M I Kaiser-Kupfer
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

8.  Molecular analysis of cystinosis: probable Irish origin of the most common French Canadian mutation.

Authors:  J McGowan-Jordan; K Stoddard; L Podolsky; E Orrbine; P McLaine; M Town; P Goodyer; A MacKenzie; H Heick
Journal:  Eur J Hum Genet       Date:  1999-09       Impact factor: 4.246

9.  Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis.

Authors:  W A Gahl; N Bashan; F Tietze; I Bernardini; J D Schulman
Journal:  Science       Date:  1982-09-24       Impact factor: 47.728

10.  Defect in vitamin B12 release from lysosomes: newly described inborn error of vitamin B12 metabolism.

Authors:  D S Rosenblatt; A Hosack; N V Matiaszuk; B A Cooper; R Laframboise
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

View more
  9 in total

Review 1.  Lysosomal membrane proteomics and biogenesis of lysosomes.

Authors:  Richard D Bagshaw; Don J Mahuran; John W Callahan
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

2.  Clinical utility gene card for: cystinosis.

Authors:  Elena Levtchenko; Lambertus van den Heuvel; Francesco Emma; Corinne Antignac
Journal:  Eur J Hum Genet       Date:  2013-09-18       Impact factor: 4.246

3.  Next generation sequencing as second-tier test in high-throughput newborn screening for nephropathic cystinosis.

Authors:  Tobias Fleige; Siegfried Burggraf; Ludwig Czibere; Julia Häring; Birgit Glück; Lisa Marie Keitel; Olfert Landt; Erik Harms; Katharina Hohenfellner; Jürgen Durner; Wulf Röschinger; Marc Becker
Journal:  Eur J Hum Genet       Date:  2019-09-30       Impact factor: 4.246

4.  Cystinosis as a lysosomal storage disease with multiple mutant alleles: Phenotypic-genotypic correlations.

Authors:  Mohammad Al-Haggar
Journal:  World J Nephrol       Date:  2013-11-06

Review 5.  New aspects of the pathogenesis of cystinosis.

Authors:  Vasiliki Kalatzis; Corinne Antignac
Journal:  Pediatr Nephrol       Date:  2003-02-27       Impact factor: 3.714

6.  Mutational Spectrum of the CTNS Gene in Egyptian Patients with Nephropathic Cystinosis.

Authors:  Neveen A Soliman; Mohamed A Elmonem; Lambertus van den Heuvel; Rehab H Abdel Hamid; Mohamed Gamal; Inge Bongaers; Sandrine Marie; Elena Levtchenko
Journal:  JIMD Rep       Date:  2014-01-25

7.  Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping.

Authors:  Aude Servais; Vincent Morinière; Jean-Pierre Grünfeld; Laure-Hélène Noël; Jean-Michel Goujon; Bernadette Chadefaux-Vekemans; Corinne Antignac
Journal:  Clin J Am Soc Nephrol       Date:  2008-01       Impact factor: 8.237

8.  Identifying putative promoter regions of Hermansky-Pudlak syndrome genes by means of phylogenetic footprinting.

Authors:  Horia Stanescu; Tyra G Wolfsberg; R Travis Moreland; Mariam H Ayub; Elizabeth Erickson; Wendy Westbroek; Marjan Huizing; William A Gahl; Amanda Helip-Wooley
Journal:  Ann Hum Genet       Date:  2009-07       Impact factor: 1.670

9.  Novel exc Genes Involved in Formation of the Tubular Excretory Canals of Caenorhabditis elegans.

Authors:  Hikmat Al-Hashimi; Travis Chiarelli; Erik A Lundquist; Matthew Buechner
Journal:  G3 (Bethesda)       Date:  2019-05-07       Impact factor: 3.154

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.